EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hepatic Progenitor Cells and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease

Pingping Wang iD, Mengjia Li iD, Ziqi Zhou, Ke Luo, Yinan Lu, Ziqiang Zhang, Jimin Su, Songjie Zhang, Yuexing Tu iD, Hongbin Luo, Qinglin Li iD, Xing Jia

Liver International · 2026-11 · 46 (11)

DOI: 10.1111/liv.70935 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver International, online erschienen am 16.10.2026. Verfasst von Pingping Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Stem Cells, Liver Diseases, Liver, Hepatocytes. Die Arbeit nennt 139 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ductular reaction (DR), a defining histological hallmark of diverse acute and chronic liver injuries, is fundamentally driven by the activation of hepatic progenitor cells (HPCs) and their complex, spatiotemporal bidirectional crosstalk within the hepatic niche. As bipotent precursor cells, HPCs initiate compensatory regeneration when mature hepatocyte proliferation is compromised. However, DR is not a uniform process but a multiphase dynamic reaction: transient early activation facilitates parenchymal restoration, whereas persistent, dysregulated HPC expansion fuels progressive fibrogenesis. The convergence of conserved developmental signalling cascades—including Hippo‐YAP, Hedgehog, Notch and TGF‐β—strictly governs HPC fate commitment and biliary epithelial proliferation. Concurrently, DR orchestrates intricate inflammatory circuitries by recruiting innate and adaptive immune cells, activating hepatic stellate cells and remodelling the extracellular matrix, thereby establishing a pro‐fibrotic niche that perpetuates chronic injury. This review systematically categorizes the disease‐specific morphological and molecular subtypes of DR across heterogeneous liver disorders, including metabolic dysfunction‐associated steatotic liver disease (MASLD), viral hepatitis and cholestatic liver diseases, highlighting its robust value as an independent histological and serological prognostic biomarker. Leveraging recent mechanistic breakthroughs from single‐cell transcriptomics, lineage tracing and spatial imaging, we comprehensively evaluate widely adopted preclinical models and summarise emerging therapeutic strategies targeting the HPC‐DR axis, such as small‐molecule compounds, phytochemicals and cytokine modulators. Despite substantial advances in deciphering the HPC‐DR axis, critical translational bottlenecks impede its clinical application. Collectively, this review integrates state‐of‐the‐art multidimensional evidence to reconstruct the pathogenic network of HPC‐DR interactions, providing mechanistic insights to facilitate precise prognostic evaluation and the development of novel targeted interventions for chronic liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stem CellsLiver DiseasesLiverHepatocytesHumansDisease ProgressionAnimalsSignal TransductionLiver Regeneration

Stichwörter der Autor:innen

ductular reactionhepatic progenitor cellsliver diseasesmolecular mechanismtherapeutic target

Autor:innen und Institutionen

  • Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University (Tongde Hospital of Zhejiang Province), Hangzhou, Zhejiang, China.

ORCID-Profile: Pingping Wang, Mengjia Li, Yuexing Tu, Qinglin Li

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • the Key Project of Medical and Health Science and Technology Plan of Zhejiang Province
  • Medical and Health Science and Technology Plan of Zhejiang Province

Zitieren

APA

Wang, P., Li, M., Zhou, Z., Luo, K., Lu, Y., Zhang, Z., Su, J., Zhang, S., Tu, Y., Luo, H., Li, Q., & Jia, X. (2026). Hepatic Progenitor Cells and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease. Liver International, 46(11). https://doi.org/10.1111/liv.70935

Vancouver

Wang P, Li M, Zhou Z, Luo K, Lu Y, Zhang Z, et al. Hepatic Progenitor Cells and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease. Liver International. 2026;46(11). doi:10.1111/liv.70935

BibTeX
@article{Wang2026,
  author = {Wang, Pingping and Li, Mengjia and Zhou, Ziqi and Luo, Ke and Lu, Yinan and Zhang, Ziqiang and Su, Jimin and Zhang, Songjie and Tu, Yuexing and Luo, Hongbin and Li, Qinglin and Jia, Xing},
  title = {Hepatic Progenitor Cells and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {11},
  doi = {10.1111/liv.70935}
}
Kostenlos starten →